welbournes

MHRA Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution (Laboratoires Théa) Drug alert number: EL(25)A/34 Date issued: 07 July 2025 Laboratoires Théa trading as Thea Pharmaceuticals Limited have notified the MHRA of an out of specification event related to environmental monitoring during manufacturing, which may increase the risk of microbial contamination of the [...]

The post Class 2 Medicines Recall: Zaditen 0.25 mg/ml, eye drops, solution (Laboratoires Théa) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: Salbutamol 100micrograms/dose breath actuated inhalers CFC free MSN/2025/041 Tier 2 – medium impact Date of issue: 04/07/2025 Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free is out of stock until mid-September 2025; following resupply, stock will [...]

The post Medicine Supply Notification: Salbutamol 100micrograms/dose breath actuated inhalers CFC free appeared first on Community Pharmacy England.

The following price concessions granted in June 2025 have rolled over to July 2025: Drug Pack size June 2025 price concession Co-amoxiclav 250mg/62mg/5ml oral suspension 100 £5.06 Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £4.79 Fenofibrate micronised 160mg tablets 28 £3.60 Nizatidine 150mg capsules 30 £21.69 Sulfasalazine 500mg tablets 112 £6.61 Please note any rolled [...]

The post Rolled over price concessions for July 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (01/07/2025) confirmed the following final list of price concessions for June 2025.  Drug Pack size Price concession Ascorbic acid 100mg tablets 28 £26.89 Co-amoxiclav 250mg/62mg/5ml oral suspension 100 £5.06 Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free 100 £4.79 Fenofibrate micronised 160mg tablets 28 £3.60 Mercaptopurine 50mg tablets [...]

The post June 2025 Price Concessions Final Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets (Erythrocin 250 Tablets) Amdipharm UK Ltd Drug alert number: EL(25)A/32 Date issued: 01 July 2025 Amdipharm UK Ltd has informed MHRA that the Patient information leaflet (PIL) in the cartons for the batch listed in this notification includes a superseded PIL. The superseded PIL used [...]

The post Class 4 Medicines Defect Notification: Erythromycin Stearate BP 250mg Tablets, Amdipharm UK Ltd appeared first on Community Pharmacy England.